Navigation Links
Pediatric Surgeon Dr. Philip K. Frykman Receives NIH Grant for Research on HAEC, a Potentially Deadly Complication Threatening Infants and Small Children.
Date:4/8/2019

Dr. Philip K. Frykman, a Los Angeles-area pediatric surgeon and scientific researcher, has been awarded a grant by the National Institutes of Health (NIH) to research immune processes that appear related to a potentially deadly complication of Hirschsprung's disease (HD), a congenital condition most often impacting the large intestine that causes severe constipation. Hirschsprung-associated enterocolitis (HAEC) is the illness’s most frequent complication. HAEC affects up to 40 percent of children with the condition, many of whom also have Down syndrome. It often leads to frequent hospitalizations and is responsible for half of the deaths in this population.

The prestigious grant will fund Dr. Frykman’s exploration of how an arm of the immune system that attacks fungus relates to HAEC. HAEC symptoms include abdominal swelling, fever, and diarrhea. In severe cases, the complication may send very young infants and children to intensive care units because of overwhelming sepsis. Dr. Frykman’s NIH grant comes on the heels of an observation, characterized as groundbreaking by experts in the field, that both increased amounts and unexpected species of fungi appear to be living in the intestines of patients who develop HAEC, compared to patients who do not develop the complication.

“When my colleagues found the higher levels of fungi, we felt it was possible we were on to something that could make a huge difference,” Dr. Frykman said. “The data at this point is highly intriguing, and I look forward to getting started doing the pure science we need before we can perhaps turn this information into something that can help treat or prevent HAEC in patients worldwide living with Hirschsprung disease,” said the physician and research scientist.

About Dr. Philip K. Frykman
Philip K. Frykman, M.D., Ph.D., M.B.A., F.A.C.S., F.A.A.P. is an internationally recognized expert in Hirschsprung disease and has published extensively on the subject. He has been awarded numerous NIH grants and is active in leadership positions in multiple consortia studying the biology of Hirschsprung disease, its surgical treatment, and complications with the aim of improving patient outcomes and quality of life. Dr. Frykman is also a very active member of the Los Angeles-area medical community as both a pediatric surgeon and a teaching physician at UCLA’s David Geffen School of Medicine and Cedars-Sinai. Dr. Frykman performs pediatric surgery in the Los Angeles area through his Thousand Oaks practice, Pacific Coast Pediatric Surgery.

Readers who would like to learn more about Dr. Frykman’s practice can call his offices at 805-372-8500 or visit it online at https://www.pacificcoastpediatricsurgery.com/.

Read the full story at https://www.prweb.com/releases/pediatric_surgeon_dr_philip_k_frykman_receives_nih_grant_for_research_on_haec_a_potentially_deadly_complication_threatening_infants_and_small_children/prweb16219739.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. HBU Secures 9 Students for New MSN in Pediatric Nurse Practitioner Primary Care Program
2. Top Acupuncture Now Providing Pediatric Acupressure Services at its Houston Clinic
3. ‘Get a Bear, Give a Bear’ with AdventHealth and the Lightning at Pediatric Health Night
4. Impact Pediatric Health Announces Twelve Finalists For Startup Pitch Competition At SXSW 2019
5. Pediatric Dentist in Sarasota, FL, Offers Anxious Patients Relaxing, Positive Experiences, Builds Healthy Dental Habits
6. White Oak Pediatrics Welcomes Alayne Benassi to its Team
7. Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients With Sickle Cell Disease Using Altemia Capsules
8. Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD
9. Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review
10. Study Finds Surfacide UV-C Light Effective as an Adjunct to Infection Control in a Pediatric Burn Hospital
11. New England Pediatric Device Consortium Awards Velano Vascular in Support of Needle Free Blood Draw Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2019)... (PRWEB) , ... June 20, 2019 , ... ... products, was recently named one of the Philadelphia Business Journal’s Healthiest Employers of ... Wellness@Work Director, Vicki Wolf, accepted the award during a ceremony at the Ballroom ...
(Date:6/20/2019)... DURHAM, N.C. (PRWEB) , ... June 20, 2019 ... ... Medicine (SCTM) demonstrates how preconditioning mesenchymal stem cells (MSCs) enhances their ability to ... way to developing more effective MSC treatments for clinical application, according to Ben ...
(Date:6/19/2019)... ... June 19, 2019 , ... ... his book Thermal and Physical Properties of Biofield Treated Bile Salt and Proteose ... including Nosology, Biophysics, Preventive Medicine, Biochemistry, Medical Technology, Pathophysiology, Molecular Biology, Science Reference ...
Breaking Medicine Technology:
(Date:6/14/2019)... ... 14, 2019 , ... United Breast Cancer Foundation ... Saturday, July 13th. UBCF is thrilled to return to the “City of Brotherly ... This second event was added after an overwhelming response to the Tempur-Pedic® Mattress ...
(Date:6/14/2019)... (PRWEB) , ... June 14, 2019 , ... This past ... dentists and their dedicated support staff hosted the Parma Heights Day of Giving, where ... informed about the event through local nonprofits that partnered with the Smiles for ...
(Date:6/13/2019)... ... June 13, 2019 , ... MMJ BioPharma Cultivation, ... signed a memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis ... , MMJ BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana ...
(Date:6/13/2019)... LAWRENCE, Mass. (PRWEB) , ... June 13, 2019 ... ... the Charm ROSA® Beta-lactam 30 Second Test (BL30SEC) has been accepted by the ... the Pasteurized Milk Ordinance Appendix N requirements. , The Charm BL30SEC test ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... their partnership with cannabis delivery company, Driven Deliveries, Inc., the only publicly traded ... covers 93% of the population of California with overnight cannabis delivery to major ...
Breaking Medicine News(10 mins):